Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Deaths: final data for 2008.

Miniño AM, Murphy SL, Xu J, Kochanek KD.

Natl Vital Stat Rep. 2011 Dec 7;59(10):1-126.

2.

Novel glutamatergic agents for major depressive disorder and bipolar disorder.

Machado-Vieira R, Ibrahim L, Henter ID, Zarate CA Jr.

Pharmacol Biochem Behav. 2012 Feb;100(4):678-87. doi: 10.1016/j.pbb.2011.09.010. Epub 2011 Sep 25. Review.

3.

Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.

Kemp DE, Ismail-Beigi F, Ganocy SJ, Conroy C, Gao K, Obral S, Fein E, Findling RL, Calabrese JR.

J Affect Disord. 2012 Feb;136(3):1164-73. doi: 10.1016/j.jad.2011.06.033. Epub 2011 Jul 22.

4.

Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease.

Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ.

Neuroreport. 2011 Aug 24;22(12):623-7. doi: 10.1097/WNR.0b013e3283497334.

5.

Deletion of the hyperpolarization-activated cyclic nucleotide-gated channel auxiliary subunit TRIP8b impairs hippocampal Ih localization and function and promotes antidepressant behavior in mice.

Lewis AS, Vaidya SP, Blaiss CA, Liu Z, Stoub TR, Brager DH, Chen X, Bender RA, Estep CM, Popov AB, Kang CE, Van Veldhoven PP, Bayliss DA, Nicholson DA, Powell CM, Johnston D, Chetkovich DM.

J Neurosci. 2011 May 18;31(20):7424-40. doi: 10.1523/JNEUROSCI.0936-11.2011.

6.

Olfactory and visuospatial learning and memory performance in two strains of Alzheimer's disease model mice--a longitudinal study.

Phillips M, Boman E, Osterman H, Willhite D, Laska M.

PLoS One. 2011 May 5;6(5):e19567. doi: 10.1371/journal.pone.0019567.

7.

Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging.

Foster TC.

Hippocampus. 2012 Apr;22(4):656-69. doi: 10.1002/hipo.20935. Epub 2011 Apr 27. Review.

9.

DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice.

Arsenault D, Julien C, Tremblay C, Calon F.

PLoS One. 2011 Feb 23;6(2):e17397. doi: 10.1371/journal.pone.0017397.

10.

The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice.

To AW, Ribe EM, Chuang TT, Schroeder JE, Lovestone S.

PLoS One. 2011 Feb 10;6(2):e16991. doi: 10.1371/journal.pone.0016991.

11.

Lipophilicity as a determinant of thiazolidinedione action in vitro: findings from BLX-1002, a novel compound without affinity to PPARs.

Brunmair B, Staniek K, Lehner Z, Dey D, Bolten CW, Stadlbauer K, Luger A, Fürnsinn C.

Am J Physiol Cell Physiol. 2011 Jun;300(6):C1386-92. doi: 10.1152/ajpcell.00401.2010. Epub 2011 Feb 23.

12.

Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.

van Groen T, Miettinen P, Kadish I.

J Alzheimers Dis. 2011;24(2):301-13. doi: 10.3233/JAD-2011-101479.

PMID:
21239852
13.

Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.

Chou JL, Shenoy DV, Thomas N, Choudhary PK, Laferla FM, Goodman SR, Breen GA.

J Proteomics. 2011 Apr 1;74(4):466-79. doi: 10.1016/j.jprot.2010.12.012. Epub 2011 Jan 13.

PMID:
21237293
14.

Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.

Rodriguez-Rivera J, Denner L, Dineley KT.

Behav Brain Res. 2011 Jan 1;216(1):255-61. doi: 10.1016/j.bbr.2010.08.002. Epub 2010 Aug 13.

15.
16.

Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.

Sterniczuk R, Antle MC, Laferla FM, Dyck RH.

Brain Res. 2010 Aug 12;1348:149-55. doi: 10.1016/j.brainres.2010.06.011. Epub 2010 Jun 15.

PMID:
20558146
17.

Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.

Woltjer RL, Duerson K, Fullmer JM, Mookherjee P, Ryan AM, Montine TJ, Kaye JA, Quinn JF, Silbert L, Erten-Lyons D, Leverenz JB, Bird TD, Pow DV, Tanaka K, Watson GS, Cook DG.

J Neuropathol Exp Neurol. 2010 Jul;69(7):667-76. doi: 10.1097/NEN.0b013e3181e24adb.

18.

Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.

Beckett TL, Niedowicz DM, Studzinski CM, Weidner AM, Webb RL, Holler CJ, Ahmed RR, LeVine H 3rd, Murphy MP.

Neurobiol Dis. 2010 Sep;39(3):449-56. doi: 10.1016/j.nbd.2010.05.018. Epub 2010 May 20.

19.

The effects of cholesterol on learning and memory.

Schreurs BG.

Neurosci Biobehav Rev. 2010 Jul;34(8):1366-79. doi: 10.1016/j.neubiorev.2010.04.010. Epub 2010 May 12. Review.

20.

Effects of long-term pioglitazone treatment on peripheral and central markers of aging.

Blalock EM, Phelps JT, Pancani T, Searcy JL, Anderson KL, Gant JC, Popovic J, Avdiushko MG, Cohen DA, Chen KC, Porter NM, Thibault O.

PLoS One. 2010 Apr 29;5(4):e10405. doi: 10.1371/journal.pone.0010405.

Supplemental Content

Support Center